Delivery Order W81XWH15D0038-0012

Award Date 10/27/17
Potential Completion Date 3/26/18
Potential Value $360K
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order under the Medical Product Research and Development Indefinite Delivery Vehicle (IDV) awarded by the Defense Health Agency (DHA) to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The $516,110.95 cost-plus-fixed-fee contract supports an HIV Cohort Study, with a period of performance through October 13, 2022. The contract does not have a set-aside designation. PPD Development LP, a highly experienced federal...
This is a federal contract award to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The $151,299.72 firm fixed-price delivery order was issued under the Medical Product Research and Development Indefinite Delivery Vehicle (IDV) with the U.S. Army Medical Command (MEDCOM). The contract does not have a set-aside designation. PPD Development LP provides comprehensive clinical trial and research support services to various federal...
This is a $304,193.20 firm fixed-price delivery order contract awarded to PPD Development LP, a global contract research organization (CRO), by the Department of the Army Medical Command for an external assessment of the U.S. Army Medical Materiel Development Activity (USAMMDA). The contract does not have a set-aside designation. As a prime contractor, PPD has extensive experience providing clinical trial and research support services to various federal agencies, including over $500 million in...
This is a firm-fixed price delivery order awarded by the Department of the Army Medical Command to PPD Development LP, a global contract research organization (CRO), in the amount of $198,044.52. The order is for labor analysis of alternatives for extremity repair in regards to vascular grafting services during the base period. This delivery order is under the Medical Product Research and Development contract vehicle. The contract has no set-aside designation. As a prime contractor, PPD has...
This is a Task Order awarded by the Department of the Army Medical Command to the prime contractor PPD Development LP under the Medical Product Research and Development (MPRD) Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. The Task Order has a potential value of $433,077.79 and is for research to identify and describe products that may be useful in the treatment, diagnosis, or prevention of human infectious diseases of concern to the U.S. military. The work is being performed...
This is a Firm Fixed Price Delivery Order awarded by the Department of the Army Medical Command to PPD Development LP, a global contract research organization (CRO), for the development of a U.S. Army Blood Products and Components Concept of Operations (CONOPS) for Damage Control Resuscitation (DCR). The contract has a potential value of $462,762.35 and was not set aside for any specific business type. The order falls under the broader Medical Product Research and Development Indefinite Delivery...
The Defense Health Agency awarded a $11.6 million delivery order against its Medical Product Research and Development master IDIQ contract to PPD Development LP. This cost-plus-fixed-fee order is to provide clinical monitoring services for a Phase 2B proof of concept study being conducted in South Africa. The study aims to develop an HIV vaccine that meets the requirements of the U.S. Military. Performance will take place in South Africa over a five year period concluding in October 2022. No set...
This is a Firm Fixed Price Delivery Order contract awarded by the U.S. Army Medical Command (MEDCOM) to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The $239,945.00 contract is part of the Medical Product Research and Development Indefinite Delivery Vehicle (IDV), and covers dengue market research services. The contract has no set-aside designation and is scheduled for completion by December 6, 2016. As a CRO, PPD Development LP has...
This contract was awarded by the Department of the Army Medical Command to PPD Development LP, a global contract research organization, to conduct research and development for a market analysis for a multiplex bioassay indicative of organ injury. The contract has a potential value of $374,428.13 and was awarded on a firm fixed price basis as a delivery order under the Medical Product Research and Development Indefinite Delivery Contract (IDC). The contract does not have a set-aside...
This is a delivery order under the Medical Countermeasures Clinical Studies Network contract vehicle, awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to PPD Development, LP, a global contract research organization (CRO). The $6,186,155.39 delivery order is for a H5N1 clinical study, under a cost-plus-fixed-fee contract type. PPD Development, LP has been awarded over $500 million in prime federal contracts and participated as a subcontractor on grants and...

The Department of the Army Medical Command awarded a $359,747 firm-fixed-price delivery order contract to PPD Development LP, a global contract research organization, for HIV vaccine market research. The contract is not set aside and is part of the Medical Product Research and Development Indefinite Delivery Contract (IDC) vehicle. PPD has extensive experience as a prime contractor and subcontractor providing clinical trial, research, regulatory, and other support services to federal agencies like the Department of Health and Human Services, Department of Defense, and National Cancer Institute. This contract supports the Army Medical Command's efforts in vaccine and medical countermeasures development.

Generated 3/23/24, 7:19 AM